Log In
Print this Print this

Staphylokinase (THR-100) (formerly Sak42D)

  Manage Alerts
Collapse Summary General Information
Company Bharat Biotech International Ltd.
DescriptionRecombinant staphylokinase variant
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase III
Standard IndicationMyocardial infarction (MI)
Indication DetailsTreat acute myocardial infarction (AMI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today